Advanced Cell Technology (OTC BB: ACTC) IRB approval to treat dry-AMD by hESC-derived retinal pigment epithelial (RPE) cells
Embryonic Stem Cell Clinical Trial for Macular Degeneration Read more…
Embryonic Stem Cell Clinical Trial for Macular Degeneration Read more…
Good morning! Here’s what you … might need to know to start the day. Read more…
The 6 W’s: Who, what, where, when, why and what of it … Read more…
End of Day, Cause and Effect … Read more…
The 6 W’s: Who, what, where, when, why and what of it … Read more…
Good morning! Here’s what you … might need to know to start the day. Read more…
End of Day, Cause and Effect … Read more…
The 6 W’s: Who, what, where, when, why and what of it … Read more…
Good morning! Here’s what you … might need to know to start the day. Read more…
End of Day, Cause and Effect … Read more…

Founder and Director of Research, Henry McCusker enters his eighth (8) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.